Omnicell OMCL
NASDAQ OMCL
$34.37 -0.45 (-1.29%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omnicell (OMCL) Notes Payables (2021 - 2025)

Omnicell's (OMCL) quarterly Notes Payables came in at $174.8 million in Q2 2025, little changed quarter-over-quarter from $174.6 million in Q1 2025.

Analysis

Omnicell (OMCL) Notes Payables (2021 - 2025) Analysis & Trends

Omnicell (OMCL) has reported Notes Payables for 4 consecutive years, with $174.8 million the latest figure, recorded in Q2 2025.

  • On a quarterly basis, Notes Payables changed N/A year-over-year to $174.8 million in Q2 2025; TTM through Jun 2025 was $174.8 million, a N/A change from a year earlier, with the FY2024 full-year figure at $174.3 million, changed N/A from the prior year.
  • Notes Payables was $174.8 million for Q2 2025 at Omnicell, roughly flat from $174.6 million in the prior quarter.
  • Over five years, Notes Payables peaked at $572.0 million in Q3 2024 and troughed at $174.3 million in Q4 2024.
  • A 4-year average of $358.0 million and a median of $331.5 million in 2021 frame the typical range for Notes Payables.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn
9 Resmed 32.94 Bn 31.47 Bn 861.22 Mn
10 Omnicell 1.57 Bn 1.28 Bn 152.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 174.80 Mn
Mar 31, 2025 174.56 Mn
Dec 31, 2024 174.32 Mn
Sep 30, 2024 572.00 Mn
Mar 31, 2022 564.27 Mn
Dec 31, 2021 488.15 Mn